Pros and Cons of Denosumab Treatment for Osteoporosis and Implication for RANKL Aptamer Therapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pros and Cons of Denosumab Treatment for Osteoporosis and Implication for RANKL Aptamer Therapy
Authors
Keywords
-
Journal
Frontiers in Cell and Developmental Biology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-05-14
DOI
10.3389/fcell.2020.00325
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives
- (2019) Marco Infante et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Author Correction to: Denosumab: A Review in Postmenopausal Osteoporosis
- (2018) Emma D. Deeks DRUGS & AGING
- THERAPY OF ENDOCRINE DISEASE: Denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis
- (2018) Athanasios D Anastasilakis et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study
- (2018) Noopur Raje et al. LANCET ONCOLOGY
- Aptamers in the Therapeutics and Diagnostics Pipelines
- (2018) Harleen Kaur et al. Theranostics
- Monoclonal antibodies for treating osteoporosis
- (2017) Maria Felicia Faienza et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib–dexamethasone in relapsed/refractory multiple myeloma: a Phase IIa Study
- (2017) H Ludwig et al. LEUKEMIA
- Drug holidays from bisphosphonates and denosumab in postmenopausal osteoporosis: EMAS position statement
- (2017) Panagiotis Anagnostis et al. MATURITAS
- Comparison of the effects of denosumab with either active vitamin D or native vitamin D on bone mineral density and bone turnover markers in postmenopausal osteoporosis
- (2017) Takako Suzuki et al. Modern Rheumatology
- The RANK/RANKL/OPG system in tumorigenesis and metastasis of cancer stem cell: potential targets for anticancer therapy
- (2017) Mekonnen Sisay et al. OncoTargets and Therapy
- Generation of Aptamers from A Primer-Free Randomized ssDNA Library Using Magnetic-Assisted Rapid Aptamer Selection
- (2017) Shih-Ming Tsao et al. Scientific Reports
- 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
- (2017) Henry G Bone et al. Lancet Diabetes & Endocrinology
- Strontium-loaded titania nanotube arrays repress osteoclast differentiation through multiple signalling pathways: In vitro and in vivo studies
- (2017) Baoguo Mi et al. Scientific Reports
- Denosumab Reduces Cortical Porosity of the Proximal Femoral Shaft in Postmenopausal Women With Osteoporosis
- (2016) Roger Zebaze et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
- (2016) P. D. Miller et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Aptamers as targeted therapeutics: current potential and challenges
- (2016) Jiehua Zhou et al. NATURE REVIEWS DRUG DISCOVERY
- Postmenopausal Osteoporosis
- (2016) Dennis M. Black et al. NEW ENGLAND JOURNAL OF MEDICINE
- Denosumab-associated hypocalcaemia: incidence, severity and patient characteristics in a tertiary hospital setting
- (2016) Andrew Liem Hieu Huynh et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Postmenopausal osteoporosis
- (2016) Richard Eastell et al. Nature Reviews Disease Primers
- Current approaches in SELEX: An update to aptamer selection technology
- (2015) Mariia Darmostuk et al. BIOTECHNOLOGY ADVANCES
- Treatment with denosumab reduces secondary fracture risk in women with postmenopausal osteoporosis
- (2015) S. Palacios et al. CLIMACTERIC
- Denosumab and osteonecrosis of the jaw. A systematic analysis of events reported in clinical trials
- (2015) Ana Boquete-Castro et al. CLINICAL ORAL IMPLANTS RESEARCH
- Peptide Aptamers: Development and Applications
- (2015) Sergey Reverdatto et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Hypocalcaemia in patients with metastatic bone disease treated with denosumab
- (2015) Jean-Jacques Body et al. EUROPEAN JOURNAL OF CANCER
- PET Imaging of Tenascin-C with a Radiolabeled Single-Stranded DNA Aptamer
- (2015) O. Jacobson et al. JOURNAL OF NUCLEAR MEDICINE
- SDF-1 Inhibition Targets the Bone Marrow Niche for Cancer Therapy
- (2014) Aldo M. Roccaro et al. Cell Reports
- Biology of the RANKL–RANK–OPG System in Immunity, Bone, and Beyond
- (2014) Matthew C. Walsh et al. Frontiers in Immunology
- The Interplay between the Bone and the Immune System
- (2013) Giorgio Mori et al. Clinical & Developmental Immunology
- Hematopoietic Stem and Progenitor Cell Mobilization in Mice and Humans by a First-in-Class Mirror-Image Oligonucleotide Inhibitor of CXCL12
- (2013) A Vater et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Public Health Impact of Osteoporosis
- (2013) J. A. Cauley JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- A review on strontium ranelate long-term antifracture efficacy in the treatment of postmenopausal osteoporosis
- (2013) Luisella Cianferotti et al. Therapeutic Advances in Musculoskeletal Disease
- Single-stranded DNA (ssDNA) production in DNA aptamer generation
- (2012) Citartan Marimuthu et al. ANALYST
- In vivo uses of aptamers selected against cell surface biomarkers for therapy and molecular imaging
- (2012) Agnes Cibiel et al. BIOCHIMIE
- RNA-Based Therapeutics: Current Progress and Future Prospects
- (2012) John C. Burnett et al. CHEMISTRY & BIOLOGY
- Role of RANK Ligand and Denosumab, a Targeted RANK Ligand Inhibitor, in Bone Health and Osteoporosis: A Review of Preclinical and Clinical Data
- (2012) David W. Dempster et al. CLINICAL THERAPEUTICS
- Generating Aptamers by Cell-SELEX for Applications in Molecular Medicine
- (2012) Mao Ye et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The birth pangs of monoclonal antibody therapeutics
- (2012) Lara Marks mAbs
- Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis
- (2012) James A. Simon et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab
- (2012) David L. Lacey et al. NATURE REVIEWS DRUG DISCOVERY
- Aptamers and Their Biological Applications
- (2012) Kyung-Mi Song et al. SENSORS
- Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab
- (2012) Athanasios Anastasilakis Therapeutics and Clinical Risk Management
- Aptamer-conjugated nanomaterials and their applications
- (2011) Liu Yang et al. ADVANCED DRUG DELIVERY REVIEWS
- Advances and Perspectives in Cell-Specific Aptamers
- (2011) Wei Sun et al. CURRENT PHARMACEUTICAL DESIGN
- Denosumab
- (2011) Lesley J. Scott et al. DRUGS
- Effects of denosumab on fracture and bone mineral density by level of kidney function
- (2011) Sophie A Jamal et al. JOURNAL OF BONE AND MINERAL RESEARCH
- PEGylated Anti-MUC1 Aptamer-Doxorubicin Complex for Targeted Drug Delivery to MCF7 Breast Cancer Cells
- (2011) Lihan Tan et al. MACROMOLECULAR BIOSCIENCE
- Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association?
- (2011) N. B. Watts et al. OSTEOPOROSIS INTERNATIONAL
- The RANKL Pathway and Denosumab
- (2011) Robin K. Dore RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Discovery and Development of Therapeutic Aptamers
- (2010) P.R. Bouchard et al. Annual Review of Pharmacology and Toxicology
- Which fractures are most attributable to osteoporosis?
- (2010) Amy H. Warriner et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial
- (2010) Gareth J Morgan et al. LANCET
- Do RANKL inhibitors (denosumab) affect inflammation and immunity?
- (2010) S. Ferrari-Lacraz et al. OSTEOPOROSIS INTERNATIONAL
- New knowledge on critical osteoclast formation and activation pathways from study of rare genetic diseases of osteoclasts: focus on the RANK/RANKL axis
- (2010) J. C. Crockett et al. OSTEOPOROSIS INTERNATIONAL
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Denosumab: Anti-RANKL antibody
- (2009) Paul D. Miller Current Osteoporosis Reports
- SELEX with modified nucleotides
- (2008) Anthony D Keefe et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Denosumab, a Fully Human Monoclonal Antibody to RANKL, Inhibits Bone Resorption and Increases BMD in Knock-In Mice That Express Chimeric (Murine/Human) RANKL*
- (2008) Paul J Kostenuik et al. JOURNAL OF BONE AND MINERAL RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now